Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8(+) T cells

Human Cytomegalovirus (CMV) reactivation remains a major source of morbidity in patients after solid organ and hematopoietic stem cell transplantation (HSCT). Adoptive T cell therapy (ACT) with CMV-specific T cells is a promising therapeutic approach for HSCT recipients, but might be counteracted by...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlott, Fabian, Steubl, Dominik, Ameres, Stefanie, Moosmann, Andreas, Dreher, Stefan, Heemann, Uwe, Hösel, Volker, Busch, Dirk H., Neuenhahn, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831000/
https://www.ncbi.nlm.nih.gov/pubmed/29489900
http://dx.doi.org/10.1371/journal.pone.0193554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831000/
https://www.ncbi.nlm.nih.gov/pubmed/29489900
http://dx.doi.org/10.1371/journal.pone.0193554

Ejemplares similares